Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

BACKGROUND: Malignant pleural mesothelioma (MPM) is a biologically highly aggressive tumor arising from the pleura with a dismal prognosis. Cisplatin is the drug of choice for the treatment of MPM, and carboplatin seems to have comparable efficacy. Nevertheless, cisplatin treatment results in a resp...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Mairinger, Fabian D., Schmeller, Jan, Borchert, Sabrina, Wessolly, Michael, Mairinger, Elena, Kollmeier, Jens, Hager, Thomas, Mairinger, Thomas, Christoph, Daniel C., Walter, Robert F.H., Eberhardt, Wilfried E.E., Plönes, Till, Wohlschlaeger, Jeremias, Jasani, Bharat, Schmid, Kurt Werner, Bankfalvi, Agnes
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2018
Subjects:
Research Paper: Pathology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5976462/
https://ncbi.nlm.nih.gov/pubmed/29854276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24962
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items